PHGE
AMEXBiomX Inc.
Price$0.13-0.00 (-0.60%)
02:30 PM07:45 PM
News · 26 weeks70-27%
2026-03-012026-08-23
Mix3990d
- SEC Filings22(56%)
- Other14(36%)
- M&A2(5%)
- Leadership1(3%)
Latest news
25 items- SECBiomX Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- SECSEC Form 10-Q filed by BiomX Inc.10-Q - BiomX Inc. (0001739174) (Filer)
- SECSEC Form NT 10-Q filed by BiomX Inc.NT 10-Q - BiomX Inc. (0001739174) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by BiomX Inc.SCHEDULE 13G/A - BiomX Inc. (0001739174) (Subject)
- PRBiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation SiteNETANYA, Israel, Aug. 14, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a company focused on defense, security and critical infrastructure technologies, today announced that its subsidiary, Zorronet Ltd. ("Zorronet"), has received an approximately $300,000 order for the planning, integration and deployment of a unified operational environment at a defense technology test and evaluation site. Under the project, Zorronet will design and establish the site’s communications, computing and control infrastructure, integrate multiple operational systems and deploy a dedicated command-and-control center. Zorronet will manage the project from initial characterization
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- SECSEC Form DEF 14A filed by BiomX Inc.DEF 14A - BiomX Inc. (0001739174) (Filer)
- PRBiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous SystemsNETANYA, Israel, Aug. 05, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a defense technology company building a portfolio of technologies to detect, analyze and respond to physical threats, today announced that it has acquired a 10% stake in M.E.A. Testing Systems Ltd. and Mea Motomova India (collectively "Motomea"), a developer of advanced electric motor testing and validation systems, including an exclusive license to develop and distribute drone testing solutions. The investment is intended to strengthen BiomX’s ability to support increasingly integrated defense systems by adding access to specialized expertise in one of the most critical components of unm
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX And Water.IO Agree To Updated Zorronet Acquisition TermsNETANYA, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a company focused on defense, security, and critical infrastructure technologies, today announced an amendment to the promissory note related to its April 2026 acquisition of Zorronet Ltd. from Water.IO Ltd. (TASE: WATR) ("Water.IO"). The amended terms are intended to provide BiomX with additional flexibility for its remaining payments to Water.IO. As part of the amendment, BiomX will issue 800,000 restricted shares of common stock to Water IO in consideration of the extension and in satisfaction of accrued interest, subject to customary conditions, including any required approvals. The r
- SECSEC Form 424B5 filed by BiomX Inc.424B5 - BiomX Inc. (0001739174) (Filer)
- PRBiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in EuropeNETANYA, Israel, July 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that its subsidiary, Zorronet Ltd. ("Zorronet"), has entered into a strategic collaboration with Samura s.r.o., a leading Czech company specializing in the distribution, implementation, and commercialization of innovative technologies across Central and Eastern Europe. The collaboration will support projects across multiple sectors, including agriculture, infrastructure, environmental monitoring, property protection, and other applications where Zorronet's technology can deliver measurable value. The collaboration demonstrates how Zorronet's AI-powered software can be app
- SECSEC Form PRE 14A filed by BiomX Inc.PRE 14A - BiomX Inc. (0001739174) (Filer)
- SECSEC Form EFFECT filed by BiomX Inc.EFFECT - BiomX Inc. (0001739174) (Filer)
- SECSEC Form 424B3 filed by BiomX Inc.424B3 - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI CapabilitiesNETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a company focused on defense, security, and critical infrastructure technologies, today announced that its wholly owned subsidiary Zorronet has completed the transition of its core operations to a new data center. The new data center is designed to improve response times and cost efficiency, and to increase capacity for handling complex security events in real time. The new data center forms a key part of Zorronet’s infrastructure modernization and supports its business expansion. "Completing the transition to a new advanced data center is an important milestone," said Idan Wasserman, CE
- PRBiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration CapabilitiesNETANYA, Israel, July 08, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a company focused on acquiring and further developing technologies that identify, analyze, protect against and support faster responses to physical threats, today announced that its wholly owned subsidiary BiomX Israel Defense and Security Ltd. has signed a non-binding letter of intent (the "LOI") to acquire a 60% controlling interest in Tsoock Defense Technologies Ltd. ("Tsoock"), an Israeli security infrastructure and systems integration company with approximately 20 years of operating experience. The LOI is non-binding with respect to the proposed transaction terms, and there can be no
- PRBiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways AgreementNETANYA, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), announced today following its April 16, 2026 announcement that its wholly-owned subsidiary Zorronet has commenced supply and installation of its AI and ML-powered detection and command-and-control systems on sections of the Israel Railways network, in accordance with the framework supply agreement, focused on protecting wildlife and safeguarding national infrastructure. Zorronet provides and installs AI, ML and business intelligence-enabled alert stations capable of detecting and deterring animals and humans, including ongoing maintenance and 24/7 service center operations. The initial ph
- SECBiomX Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- SECSEC Form S-8 filed by BiomX Inc.S-8 - BiomX Inc. (0001739174) (Filer)
- SECSEC Form S-1 filed by BiomX Inc.S-1 - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026NETANYA, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that its majority-owned subsidiary company DFSL Ltd. ("DFSL") will showcase next-generation LADAR-based counter-drone and perimeter security solutions at ISC 2026. DFSL’s proprietary Laser Radar (LADAR) platform, enhanced by on-sensor AI algorithms, delivers real-time detection, classification, and tracking of UAVs and ground intruders with approximately 99% accuracy in demanding real-world environments. Designed to minimize false alarms that plague conventional systems, DFSL’s technology is designed to provide a reliable "last line of detection" for high-stakes application
- SECSEC Form DEFA14A filed by BiomX Inc.DEFA14A - BiomX Inc. (0001739174) (Filer)
PHGE FAQ
7 questionsWhat does BiomX Inc. do?
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). The company's lead product candidate BX001, which is in Phase II that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type. Its products under...Where does PHGE stock trade?
BiomX Inc. (PHGE) is listed on AMEX.What sector and industry is PHGE in?
BiomX Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did BiomX Inc. go public?
BiomX Inc. (PHGE) completed its IPO in 2019.What are analysts saying about PHGE?
BiomX Inc. has had 3 recent analyst actions on file. The most recent action was from Chardan Capital: Buy with a $1300.00 price target on 2021-11-16. Recent price targets range from $1000.00 to $1600.00.What companies are similar to PHGE?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare PHGE side-by-side with any of them on Quantisnow.How can I track PHGE on Quantisnow?
Quantisnow aggregates BiomX Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PHGE to receive live email and push alerts on every new disclosure.